Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
Evan L. Barrios, Monty B. Mazer, Patrick W. McGonagill, Christian B. Bergmann, Michael D. Goodman, Robert W. Gould, Mahil Rao, Valerie E. Polcz, Ruth J. Davis, Drew E. Del Toro, Marvin L.S. Dirain, Alexandra Dram, Lucas O. Hale, Mohammad Heidarian, Caleb Y. Kim, Tamara A. Kucaba, Jennifer P. Lanz, Ashley E. McCray, Sandra Meszaros, Sydney MilesCandace R. Nelson, Ivanna L. Rocha, Elvia E. Silva, Ricardo F. Ungaro, Andrew H. Walton, Julie Xu, Leilani Zeumer-Spataro, Anne M. Drewry, Muxuan Liang, Letitia E. Bible, Tyler J. Loftus, Isaiah R. Turnbull, Philip A. Efron, Kenneth E. Remy, Scott C. Brakenridge, Vladimir P. Badovinac, Thomas S. Griffith, Lyle L. Moldawer, Richard S. Hotchkiss, Charles C. Caldwell
Dive into the research topics of 'Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot'. Together they form a unique fingerprint.